Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Total 13F shares
-
4,134,096
-
Share change
-
+439,516
-
Total reported value
-
$95,964,212
-
Price per share
-
$23.21
-
Number of holders
-
62
-
Value change
-
+$10,571,291
-
Number of buys
-
40
-
Number of sells
-
24
Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2020
As of 30 Jun 2020,
IRADIMED CORP - Common Stock (IRMD) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,134,096 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Nine Ten Capital Management LLC, Russell Investments Group, Ltd., Ranger Investment Management, L.P., RK Capital Management, LLC, Soleus Capital Management, L.P., Mondrian Investment Partners LTD, RICE HALL JAMES & ASSOCIATES, LLC, and NORTHERN TRUST CORP.
This page lists
62
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.